You have 9 free searches left this month | for more free features.

Vinorelbine

Showing 576 - 598 of 598

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced NSCLC Trial in Italy (Pemetrexed, Pemetrexed plus carboplatin)

Unknown status
  • Advanced Non-Small Cell Lung Cancer
  • Ancona, Italy
  • +20 more
Jul 31, 2009

Locally Advanced Non Small-Cell Lung Canger Trial in Mexico city (Transdermal nitroglycerin)

Unknown status
  • Locally Advanced Non Small-Cell Lung Canger
  • Transdermal nitroglycerin
  • Mexico city, Distrito federal, Mexico
    National Institute of Cancerología
Apr 21, 2009

NSCLC Trial in Germany (Sorafenib)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Essen, Germany
  • +5 more
Jul 24, 2009

Non Small Cell Lung Cancer Trial in Guangzhou (Pemetrexed/Oxaliplatin)

Unknown status
  • Non Small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Guangzhou Medical College
Jun 17, 2009

Metastatic Breast Cancer Trial in Columbus, Newark (Doxil and Vinorelbine)

Unknown status
  • Metastatic Breast Cancer
  • Doxil and Vinorelbine
  • Columbus, Ohio
  • +1 more
May 30, 2008

NSCLC Trial in Taipei (Taxotere, Cisplatin, Gemcitabine)

Unknown status
  • Carcinoma, Non-Small-Cell Lung
  • Taxotere, Cisplatin, Gemcitabine
  • Taipei, Ban-Ciao, Taiwan
    Chi-Huang Hsiao
Feb 6, 2009

Breast Cancer Trial in Copenhagen (docetaxel, vinorelbine, trastuzumab)

Unknown status
  • Breast Cancer
  • Copenhagen, Denmark
    Department of Oncology, Rigshospitalet
May 6, 2008

Cancer Trial (Topotecan, Docetaxel)

Completed
  • Cancer
  • (no location specified)
Jan 22, 2009

NSCLC, Measles Trial in Beer Sheva (attenuated measles vaccine)

Unknown status
  • Non-Small Cell Lung Cancer
  • Measles
  • attenuated measles vaccine
  • Beer Sheva, Israel
    Department of Oncology, Soroka Medical Center
Jan 22, 2009

NSCLC Trial in Germany (Erlotinib, Vinorelbine and Carboplatin)

Unknown status
  • Non-Small Cell Lung Cancer
  • Augsburg, Germany
  • +39 more
May 15, 2008

Breast Cancer, Cancer, Lung Cancer Trial run by the NCI (Vinorelbine, XR9576)

Completed
  • Breast Cancer
  • +3 more
  • Bethesda, Maryland
    National Cancer Institute (NCI)
Mar 3, 2008

Breast Cancer, Non Small Cell Lung Cancer, Prostate Cancer Trial in Greece (vinorelbine oral formulation)

Completed
  • Breast Cancer
  • +2 more
  • vinorelbine oral formulation
  • Athens, Greece
  • +10 more
Feb 27, 2008

Sarcoma, Soft Tissue Trial in Boston (gemcitabine, vinorelbine)

Completed
  • Sarcoma, Soft Tissue
  • Boston, Massachusetts
  • +1 more
Dec 20, 2007

NSCLC Trial in France (Gefitinib, Radiation therapy, Cisplatin)

Completed
  • Non-Small Cell Lung Cancer
  • Clermont Ferrand, France
  • +3 more
Dec 16, 2007

Breast Tumor Trial in Seattle (Docetaxel, Vinorelbine, Filgrastim)

Completed
  • Breast Neoplasm
  • Seattle, Washington
    University of Washington/Seattle Cancer Care Alliance
Dec 3, 2007

Non-Small-Cell Lung Carcinoma Trial in Kassel (Gemcitabine, Navelbine, Carboplatin)

Completed
  • Non-Small-Cell Lung Carcinoma
  • Kassel, Germany
    Klinikum Kassel GmbH
Apr 21, 2008

Breast Cancer Trial in Egypt (gemcitabine, vinorelbine)

Completed
  • Breast Cancer
  • Alexandria, Egypt
  • +3 more
Aug 29, 2007

NSCLC Trial in cOIMBRA (CETUXIMAB)

Unknown status
  • Carcinoma, Non-Small-Cell Lung
  • cOIMBRA, Portugal
    fERNANDO bARATA
Nov 19, 2007

NSCLC Trial in Berlin (Carboplatin, Paclitaxel, Vinorelbine)

Unknown status
  • Carcinoma, Non-Small-Cell Lung
  • Berlin, Germany
    Hematology & Oncology Charité CBF Berlin
Oct 31, 2006

Rhabdomyosarcomas, Tumors, Connective and Soft Tissue, Ewing Tumor Trial in Villejuif (Vinorelbine, cyclofosfamide)

Unknown status
  • Rhabdomyosarcomas
  • +5 more
  • Vinorelbine, cyclofosfamide
  • Villejuif, France
    Institut Gustave-Roussy
Sep 7, 2006

NSCLC Trial in United States (calcitriol + docetaxel)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • calcitriol + docetaxel
  • Berkeley, California
  • +10 more
May 3, 2007

Lung Cancer Trial (Patients were randomized to receive either docetaxel 60 mg/m2 on day 1 or vinorelbine 25 mg/m2 on days 1and

Completed
  • Lung Cancer
  • Patients were randomized to receive either docetaxel 60 mg/m2 on day 1 or vinorelbine 25 mg/m2 on days 1and 8, repeated every 21 days over four cycles.
  • (no location specified)
Jan 5, 2006

NSCLC Trial in Seoul (vinorelbine, gemcitabine and carboplatin)

Unknown status
  • Non-Small Cell Lung Cancer
  • vinorelbine, gemcitabine and carboplatin
  • Seoul, Korea, Republic of
    Inje University Sanggyepaik Hospital
Dec 14, 2005